Government Tender Published for Cap Ca Pantothenate 50mg plus Vit B12 Mononitrate 10mg plus Riboflavine 10mg15mcg,Cap Deferiprone 5

The eligibility requirements include being a legally registered entity, possessing necessary certifications to distribute pharmaceuticals, and compliance with regulatory mandates from health authorities. Participants must prove their capability to supply the specified medicines, demonstrating prior experience or partnerships with recognized health sectors.

Bidders should provide relevant certifications that demonstrate compliance with Good Manufacturing Practices (GMP) and other required health regulations. Certificates of analysis for products and proof of registration with health authorities may also be required.

The registration process involves creating an account on the official tender submission portal and completing requisite information regarding your company, including verification of the eligibility documents and certifications specified in the tender.

Documents must typically be submitted in widely recognized formats such as PDF, DOCX, or spreadsheet formats. It's essential for bidders to ensure their submissions adhere to the specified document types indicated in the tender to avoid disqualification.

The medicines must align with recognized quality standards as set by regulatory bodies. This includes adherence to dosage specifications, active ingredients, and labeling requirements as stipulated in the tender document.

Yes, compliance with established quality standards such as those outlined by the World Health Organization (WHO), or respective national health guidelines, is mandatory. Products must be manufactured under stringent quality checks to ensure safety and efficacy.

Bidders may be required to submit a performance security guarantee to ensure fulfillment of contract terms. This is typically a percentage of the bid value and serves to protect the interests of the purchasing authority.

Bidders must submit an Earnest Money Deposit (EMD) amounting to 589 as part of the tender process. The EMD should be in the form of a bank guarantee or demand draft, as specified.

The payment terms will be discussed post-award of contract but typically include milestone payments correlated with delivery and acceptance of supplied medicines.

The price evaluation is a critical component and focuses on ensuring competitive pricing among bidders. The lowest responsive bid that meets quality specifications will generally be favored in the evaluation process.

The key timelines involve the bid end date and bid opening date. It is crucial for bidders to ensure submissions are completed prior to the end date to guarantee consideration.

The evaluation will follow a multi-step process where both technical compliance and financial bids are assessed. Structure and clarity in documentation will ensure a favorable evaluation outcome.

Yes, MSEs will receive special considerations in the evaluation process. This may include scoring advantages and the potential for relaxed criteria depending on the particulars of their submissions.

Startups that meet specific eligibility criteria may receive favorable evaluation scores, incentivized to promote innovation within the pharmaceutical supply chain.

The tender encourages local manufacturing and procurement within the framework of the 'Make in India' initiative, which aims to bolster domestic production and utilization of local resources in supply chains.

Bidders must adhere to local content procurement rules that indicate the percentage of goods or services that should be sourced locally, aligning with government policies favoring indigenous production.